Table 2.
Information of 15 pathways
| Term ID | Description | LogP | Count |
|---|---|---|---|
| hsa05200 | Pathways in cancer | −26.20 | 32 |
| hsa05418 | Fluid shear stress and atherosclerosis | −25.80 | 23 |
| hsa04933 | AGE-RAGE signaling pathway in diabetic complications | −19.57 | 17 |
| hsa04659 | Th17 cell differentiation | −17.43 | 16 |
| hsa04151 | PI3K-Akt signaling pathway | −16.96 | 23 |
| hsa04657 | IL-17 signaling pathway | −16.88 | 15 |
| hsa05215 | Prostate cancer | −14.23 | 13 |
| hsa01522 | Endocrine resistance | −13.66 | 13 |
| hsa04066 | HIF-1 signaling pathway | −13.36 | 13 |
| hsa01521 | EGFR tyrosine kinase inhibitor resistance | −13.26 | 12 |
| hsa04668 | TNF signaling pathway | −11.59 | 12 |
| hsa04071 | Sphingolipid signaling pathway | −11.13 | 12 |
| hsa04915 | Estrogen signaling pathway | −10.72 | 11 |
| hsa04722 | Neurotrophin signaling pathway | −9.79 | 11 |
| hsa05212 | Pancreatic cancer | −9.76 | 9 |